Plus   Neg

Stock Alert: BioNTech Up 65%; To Co-Develop Coronavirus Vaccine With Pfizer

Shares of BioNTech SE (BNTX) are currently gaining over 65% on Tuesday morning after the company announced that it will team up with pharma giant Pfizer Inc. (PFE) to develop a potential vaccine for coronavirus Covid-19.

The companies will jointly develop BioNTech's mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. The companies have singed a letter of intent regarding the co-development and distribution, excluding China.

The latest collaboration builds on a 2018 agreement between the two companies to develop mRNA-based vaccines for prevention of influenza.

The companies will start working together immediately. Pfizer and BioNTech will use research and development sites from both companies, including in the US and Germany.

Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development & Medical, Pfizer, said, "We believe that by pairing Pfizer's development, regulatory and commercial capabilities with BioNTech's mRNA vaccine technology and expertise as one of the industry leaders, we are reinforcing our commitment to do everything we can to combat this escalating pandemic, as quickly as possible."

The coronavirus pandemic has so far infected nearly 179,000 people globally and killed more than 7,000.

BNTX is currently trading at $65.96, up $25.96 or 64.89%, on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT